title: [Pharmacological and clinical profile of finasteride (PROPECIA)].
authors.affiliation: hitoshi_fukuzumi@merck.com
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Fukuzumi
authors.forename: Takanori
authors.initials: T
authors.lastname: Ikeda
authors.forename: Hirohisa
authors.initials: H
authors.lastname: Narita
authors.forename: Takatoshi
authors.initials: T
authors.lastname: Takubo
authors.forename: Takuma
authors.initials: T
authors.lastname: Matsuda
authors.forename: Tadaaki
authors.initials: T
authors.lastname: Taniguchi
mesh_terms: D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000172:deficiency / Q000235:genetics; D058891:5-alpha Reductase Inhibitors; D000505:Alopecia / Q000188:drug therapy* / Q000209:etiology; D000818:Animals; D002986:Clinical Trials as Topic; D013196:Dihydrotestosterone / Q000378:metabolism; D004195:Disease Models, Animal; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D005260:Female; D018120:Finasteride / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D000882:Haplorhini; D006801:Humans; D008297:Male
chemical_list: D058891:5-alpha Reductase Inhibitors; D004791:Enzyme Inhibitors; D013196:Dihydrotestosterone; D018120:Finasteride; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase